1. Home
  2. RVSB vs RCEL Comparison

RVSB vs RCEL Comparison

Compare RVSB & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Riverview Bancorp Inc

RVSB

Riverview Bancorp Inc

HOLD

Current Price

$5.77

Market Cap

117.2M

Sector

Finance

ML Signal

HOLD

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

HOLD

Current Price

$4.11

Market Cap

129.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVSB
RCEL
Founded
1923
N/A
Country
United States
United States
Employees
N/A
226
Industry
Savings Institutions
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
117.2M
129.3M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
RVSB
RCEL
Price
$5.77
$4.11
Analyst Decision
Buy
Buy
Analyst Count
1
5
Target Price
$7.00
$7.88
AVG Volume (30 Days)
30.0K
258.0K
Earning Date
04-28-2026
05-14-2026
Dividend Yield
1.55%
N/A
EPS Growth
N/A
N/A
EPS
0.18
N/A
Revenue
N/A
N/A
Revenue This Year
$53.63
$17.17
Revenue Next Year
N/A
$49.82
P/E Ratio
$31.94
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.74
$3.22
52 Week High
$5.85
$7.12

Technical Indicators

Market Signals
Indicator
RVSB
RCEL
Relative Strength Index (RSI) 65.88 44.38
Support Level $5.02 $4.00
Resistance Level $5.84 $5.75
Average True Range (ATR) 0.13 0.30
MACD 0.01 -0.02
Stochastic Oscillator 95.24 17.78

Price Performance

Historical Comparison
RVSB
RCEL

About RVSB Riverview Bancorp Inc

Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.

About RCEL Avita Medical Inc.

Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: